Comparative Effects of Sertraline, Methotrexate, and Biologic Therapies on Circulating Inflammatory and Neurotrophic Mediators and Striatal Gene Expression in Collagen-Induced Arthritis
International Journal of Molecular Sciences · 21.08.2026 · 27 (16) · 7471
DOI: 10.3390/ijms27167471 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.08.2026. Verfasst von Grzegorz Chmielewski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland. Hauptthemen laut MEDLINE: Methotrexate, Sertraline, Arthritis, Experimental, Inflammation Mediators. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Minister of Science.
Abstract (Originalsprache)
Rheumatoid arthritis is often accompanied by neuropsychiatric manifestations, suggesting interactions between systemic inflammation and the central nervous system. This study evaluated the effects of sertraline, compared with methotrexate, infliximab, and tocilizumab, on circulating inflammatory and neurotrophic mediators and the striatal expression of selected CNS-related genes in collagen-induced arthritis. Male Wistar rats were assigned to seven groups: adjuvant control, untreated arthritis, methotrexate, sertraline, methotrexate plus sertraline, infliximab, or tocilizumab. At week 12, circulating IL-6, IL-15, IL-10, BDNF, myostatin, and irisin were measured, and striatal BDNF, IL-1β, and GFAP expression was assessed by quantitative real-time PCR. IL-6 concentrations differed between groups, with the lowest values after infliximab treatment and the highest in untreated arthritic rats and animals receiving methotrexate plus sertraline or tocilizumab. IL-15 was highest in untreated arthritis, whereas IL-10 was generally higher in treated groups and peaked after tocilizumab. The IL-6/IL-10 ratio was lower in all treated groups than in untreated arthritis, with the most pronounced reduction observed after infliximab. Circulating BDNF concentrations were highest in the infliximab- and tocilizumab-treated groups. Striatal BDNF expression differed significantly between groups, whereas no significant between-group differences were detected in striatal GFAP or IL-1β expression. No significant between-group differences were observed for circulating myostatin or irisin. Sertraline-containing regimens were associated with lower IL-6/IL-10 ratios than untreated arthritis, whereas infliximab and tocilizumab were associated with the most pronounced changes in systemic inflammatory and neurotrophic parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.
- Department of Pathological Anatomy, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.
- Department of Human Physiology and Pathophysiology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.
- Department of Dermatology, Sexually Transmitted Diseases and Clinical Immunology, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.
- Department of Microbiology and Clinical Immunology, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.
- Department of Pharmacology and Toxicology, Faculty of Medicine, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland.
ORCID-Profile: Grzegorz Chmielewski, Mateusz Mikiewicz, Jakub Kuna, Łukasz Jaśkiewicz, Joanna Czerwińska, Małgorzata Wróbel, Edyta Kaczorek-Łukowska, Michał S Majewski, Magdalena Krajewska-Włodarczyk
Förderung
- Minister of Science
Zitieren
APA
Chmielewski, G., Mikiewicz, M., Kuna, J., Jaśkiewicz, Ł., Czerwińska, J., Wróbel, M., Kaczorek-Łukowska, E., Majewski, M. S., & Krajewska-Włodarczyk, M. (2026). Comparative Effects of Sertraline, Methotrexate, and Biologic Therapies on Circulating Inflammatory and Neurotrophic Mediators and Striatal Gene Expression in Collagen-Induced Arthritis. International Journal of Molecular Sciences, 27(16), 7471. https://doi.org/10.3390/ijms27167471
Vancouver
Chmielewski G, Mikiewicz M, Kuna J, Jaśkiewicz Ł, Czerwińska J, Wróbel M, et al. Comparative Effects of Sertraline, Methotrexate, and Biologic Therapies on Circulating Inflammatory and Neurotrophic Mediators and Striatal Gene Expression in Collagen-Induced Arthritis. International Journal of Molecular Sciences. 2026;27(16):7471. doi:10.3390/ijms27167471
BibTeX
@article{Chmielewski2026,
author = {Chmielewski, Grzegorz and Mikiewicz, Mateusz and Kuna, Jakub and Jaśkiewicz, Łukasz and Czerwińska, Joanna and Wróbel, Małgorzata and Kaczorek-Łukowska, Edyta and Majewski, Michał S and Krajewska-Włodarczyk, Magdalena},
title = {Comparative Effects of Sertraline, Methotrexate, and Biologic Therapies on Circulating Inflammatory and Neurotrophic Mediators and Striatal Gene Expression in Collagen-Induced Arthritis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {16},
pages = {7471},
doi = {10.3390/ijms27167471}
}
EUVIMED